You can now order (at no cost) a copy of these resources through our secure eCart or alternatively email head office at

MSAG Clinical Practice Guidelines

Multiple Myeloma

Bortezomib, Lenalidomide and Dexamethasone for the Initial Treatment of Multiple Myeloma

Infection Prevention

Management of Systemic AL Amyloidosis

Waldenstrom Macroglobulinaemia V.1

Waldenstrom Macroglobulinaemia V.2

Position Statements

Treatment of Stem Cell Transplant Eligible Patients

Bisphosphonate guidelines for treatment and prevention of myeloma bone disease

Australia and New Zealand Consensus Statement on the Management of Lymphoma, CLL and Myeloma During the COVID-19 Pandemic

National Strategic Action Plan for Blood Cancer

COVID-19 Vaccination in Haematology Patients: An Australia and New Zealand Consensus Position Statement

Information Sheets

Useful Websites

Chronic Disease Management Plan Medicare Australia

The FISH test in Multiple Myeloma

Living with Myeloma – A personal reflection

Myeloma Bone Disease and Bisphosphonates

Exercise and Myeloma

Nutrition and Myeloma

Pain and Myeloma

Treatment Fact Sheets

CAR-T Cell Therapy Fact Sheet

Belantamab mafodotin (Blenrep®) Treatment Fact Sheet

Elotuzumab (Empliciti®) Treatment Fact Sheet

Selinexor (Xpovio®) Treatment Fact Sheet

Thalidomide Treatment Fact Sheet

Lenalidomide Treatment Fact Sheet

Pomalidomide Treatment Fact Sheet

Bortezomib Treatment Fact Sheet

Carfilzomib Treatment Fact Sheet

Ixazomib Treatment Fact Sheet

Daratumumab Treatment Fact Sheet

Venetoclax Treatment Fact Sheet

Steroids Treatment Fact Sheet

Myeloma UK Online Nurse Learning Programme